Structures by: Zeng H. S.
Total: 23
3,5-Dimethoxybenzamide oxime
C9H12N2O3
Acta Crystallographica Section E (2007) 63, 7 o3279-o3279
a=6.4390(13)Å b=8.0840(16)Å c=10.188(2)Å
α=71.29(3)° β=81.60(3)° γ=74.21(3)°
N'-Hydroxynicotinamidine
C6H7N3O
Acta Crystallographica Section E (2007) 63, 10 o4151-o4151
a=5.5220(11)Å b=12.365(3)Å c=9.797(2)Å
α=90.00° β=94.38(3)° γ=90.00°
2-tert-Butyl 4-ethyl 3,5-dimethyl-1H-pyrrole-2,4-dicarboxylate
C14H21NO4
Acta Crystallographica Section E (2007) 63, 10 o4186-o4186
a=18.570(4)Å b=7.1420(14)Å c=12.431(3)Å
α=90.00° β=116.46(3)° γ=90.00°
2-Chloro-3-(2,2,2-trifluoroethoxy)pyridine
C7H5ClF3NO
Acta Crystallographica Section E (2007) 63, 11 o4355-o4355
a=12.907(3)Å b=7.469(2)Å c=18.520(4)Å
α=90.00° β=90.00° γ=90.00°
2-{2-[3-(3,5-Dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]phenoxy}- N-(2,6-dimethylphenyl)acetamide
C26H25N3O5
Acta Crystallographica Section E (2007) 63, 11 o4314-o4314
a=7.3200(15)Å b=12.630(3)Å c=13.106(3)Å
α=95.37(3)° β=101.06(3)° γ=103.48(3)°
5-Chloromethyl-3-(3,5-dimethoxyphenyl)-1,2,4-oxadiazole
C11H11ClN2O3
Acta Crystallographica Section E (2007) 63, 11 o4234-o4234
a=7.861(2)Å b=8.502(2)Å c=9.537(2)Å
α=80.72(3)° β=73.90(3)° γ=70.09(3)°
2-Methyl-5-[3-(4-nitrophenyl)-1,2,4-oxadiazol-5-ylmethylenesulfanyl]-1,3,4- thiadiazole
C12H9N5O3S2
Acta Crystallographica Section E (2007) 63, 11 o4236-o4236
a=35.939(7)Å b=5.6540(11)Å c=13.714(3)Å
α=90.00° β=92.55(3)° γ=90.00°
2-Methyl-5-{3-[4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-ylmethylsulfanyl}- 1,3,4-thiadiazole
C13H12N4O3S3
Acta Crystallographica Section E (2007) 63, 11 o4356-o4356
a=12.365(3)Å b=15.956(3)Å c=8.2400(16)Å
α=90.00° β=108.26(3)° γ=90.00°
2-Methyl-5-{[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]methylsulfanyl}- 1,3,4-thiadiazole
C13H12N4OS2
Acta Crystallographica Section E (2007) 63, 12 o4934-o4934
a=16.751(3)Å b=10.686(2)Å c=8.0940(16)Å
α=90.00° β=97.12(3)° γ=90.00°
3-(3-Methoxyphenyl)-5-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]- 1,2,4-oxadiazole
C13H12N4O2S2
Acta Crystallographica Section E (2007) 63, 12 o4776-o4776
a=6.1390(10)Å b=9.890(2)Å c=12.658(3)Å
α=72.45(3)° β=85.91(3)° γ=77.12(3)°
3,4-Dibutoxy-<i>N</i>^2^,<i>N</i>^2'^-bis(propan-2-ylidene)thiophene-2,5- dicarbohydrazide
C20H32N4O4S
Acta Crystallographica Section E (2007) 63, 12 o4762-o4762
a=20.891(4)Å b=10.526(2)Å c=13.581(3)Å
α=90.00° β=128.24(3)° γ=90.00°
Ethyl 5-formyl-2,4-dimethyl-1<i>H</i>-pyrrole-3-carboxylate
C10H13NO3
Acta Crystallographica Section E (2008) 64, 6 o1125
a=3.9830(8)Å b=15.572(3)Å c=16.213(3)Å
α=90.00° β=96.96(3)° γ=90.00°
2-Chloro-<i>N</i>-(4-fluorophenyl)acetamide
C8H7ClFNO
Acta Crystallographica Section E (2008) 64, 7 o1194
a=4.7410(9)Å b=20.062(4)Å c=8.9860(18)Å
α=90.00° β=99.60(3)° γ=90.00°
2-[3-(4-Bromophenyl)-1,2,4-oxadiazol-5-yl]phenol
C14H9BrN2O2
Acta Crystallographica Section E (2007) 63, 12 o4697-o4697
a=6.3950(13)Å b=5.0790(10)Å c=19.625(4)Å
α=90.00° β=98.65(3)° γ=90.00°
2-(2-{3-[4-(Dimethylamino)phenyl]-1,2,4-oxadiazol-5-yl}phenoxy)-\ N-(2,6-dimethylphenyl)acetamide
C26H26N4O3
Acta Crystallographica Section E (2007) 63, 12 o4745-o4745
a=8.9900(18)Å b=9.0330(18)Å c=15.445(3)Å
α=83.01(3)° β=79.76(3)° γ=66.54(3)°
2-Methyl-5-[3-(2-methylphenyl)-1,2,4-oxadiazol-5-ylmethylsulfanyl]- 1,3,4-thiadiazole
C13H12N4OS2
Acta Crystallographica Section E (2007) 63, 12 o4586-o4586
a=10.309(2)Å b=12.992(3)Å c=10.600(2)Å
α=90.00° β=100.63(3)° γ=90.00°
4-(3-(Chloromethyl)-1,2,4-oxadiazol-5-yl)pyridine
C8H6ClN3O
Acta Crystallographica Section E (2007) 63, 12 o4654-o4654
a=10.512(2)Å b=11.486(2)Å c=7.2080(14)Å
α=90.00° β=94.11(3)° γ=90.00°
5-(Chloromethyl)-3-(2-chlorophenyl)-1,2,4-oxadiazole
C9H6Cl2N2O
Acta Crystallographica Section E (2007) 63, 12 o4746-o4746
a=10.396(2)Å b=10.302(2)Å c=9.2070(18)Å
α=90.00° β=98.30(3)° γ=90.00°
4-Chlorobenzamidoxime
C7H7ClN2O
Acta Crystallographica Section E (2007) 63, 12 o4698-o4698
a=7.9930(16)Å b=12.806(3)Å c=7.6740(15)Å
α=90.00° β=90.96(3)° γ=90.00°
2-[3,4-Dibutoxy-5-(5-phenyl-1,3,4-oxadiazol-2-yl)-2-thienyl]- 5-phenyl-1,3,4-oxadiazole
C28H28N4O4S
Acta Crystallographica Section E (2008) 64, 8 o1419
a=7.6770(15)Å b=16.871(3)Å c=20.398(4)Å
α=90.00° β=93.77(3)° γ=90.00°
5-Chloromethyl-3-(4-methylphenyl)-1,2,4-oxadiazole
C10H9ClN2O
Acta Crystallographica Section E (2007) 63, 12 o4619-o4619
a=25.462(5)Å b=6.4040(13)Å c=14.589(3)Å
α=90.00° β=122.83(3)° γ=90.00°
4-Methoxybenzamide oxime
C8H10N2O2
Acta Crystallographica Section E (2007) 63, 12 o4763-o4763
a=14.924(3)Å b=5.0820(10)Å c=10.784(2)Å
α=90.00° β=98.32(3)° γ=90.00°
5,5'-Diethyl-2,2'-(triazene-1,3-diyl)di-1,3,4-thiadiazole
C8H11N7S2
Acta Crystallographica Section E (2008) 64, 11 o2166
a=12.188(2)Å b=9.1460(18)Å c=12.790(3)Å
α=90.00° β=110.99(3)° γ=90.00°